FONAR Corporation (FONR)
USD 13.49
(-2.25%)
USD 13.49
(-2.25%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 | 45.14 Million USD | -1.33% |
| 2023 | 45.74 Million USD | -2.69% |
| 2022 | 47.01 Million USD | 8.14% |
| 2021 | 43.47 Million USD | 2.55% |
| 2020 | 42.39 Million USD | -1.89% |
| 2019 | 43.2 Million USD | 9.21% |
| 2018 | 39.56 Million USD | -1.05% |
| 2017 | 39.98 Million USD | 15.91% |
| 2016 | 34.49 Million USD | 12.56% |
| 2015 | 30.64 Million USD | -1.96% |
| 2014 | 31.25 Million USD | 35.78% |
| 2013 | 23.02 Million USD | 26.15% |
| 2012 | 18.24 Million USD | 24.51% |
| 2011 | 14.65 Million USD | 11.08% |
| 2010 | 13.19 Million USD | -25.02% |
| 2009 | 17.59 Million USD | 64.86% |
| 2008 | 10.67 Million USD | 62.95% |
| 2007 | 6.55 Million USD | 6.93% |
| 2006 | 6.12 Million USD | -83.95% |
| 2005 | 38.17 Million USD | 40.35% |
| 2004 | 27.2 Million USD | 33.25% |
| 2003 | 20.41 Million USD | 10.74% |
| 2002 | 18.43 Million USD | 27.34% |
| 2001 | 14.47 Million USD | 19.69% |
| 2000 | 12.09 Million USD | 9.95% |
| 1999 | 11 Million USD | 74.6% |
| 1998 | 6.3 Million USD | 8.62% |
| 1997 | 5.8 Million USD | -9.38% |
| 1996 | 6.4 Million USD | -14.67% |
| 1995 | 7.5 Million USD | -26.47% |
| 1994 | 10.2 Million USD | 6.25% |
| 1993 | 9.6 Million USD | -18.64% |
| 1992 | 11.8 Million USD | -16.31% |
| 1991 | 14.1 Million USD | -18.5% |
| 1990 | 17.3 Million USD | 10.19% |
| 1989 | 15.7 Million USD | -33.19% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q3 | 11.75 Million USD | 7.94% |
| 2024 Q2 | 10.88 Million USD | 552.91% |
| 2024 Q1 | -2.4 Million USD | -119.64% |
| 2024 Q4 | 10.59 Million USD | -9.85% |
| 2023 Q4 | 12.23 Million USD | 4.21% |
| 2023 FY | 45.74 Million USD | -2.69% |
| 2023 Q1 | 10.59 Million USD | -12.55% |
| 2023 Q2 | 11.17 Million USD | 5.46% |
| 2023 Q3 | 11.74 Million USD | 5.13% |
| 2022 FY | 47.01 Million USD | 8.14% |
| 2022 Q1 | 11.21 Million USD | -7.74% |
| 2022 Q4 | 12.11 Million USD | 0.45% |
| 2022 Q3 | 12.06 Million USD | 3.76% |
| 2022 Q2 | 11.62 Million USD | 3.62% |
| 2021 Q3 | 10.65 Million USD | 7.12% |
| 2021 FY | 43.47 Million USD | 2.55% |
| 2021 Q1 | 10.71 Million USD | -10.66% |
| 2021 Q2 | 9.94 Million USD | -7.15% |
| 2021 Q4 | 12.15 Million USD | 14.11% |
| 2020 Q4 | 11.99 Million USD | 15.58% |
| 2020 FY | 42.39 Million USD | -1.89% |
| 2020 Q1 | 10.25 Million USD | -8.79% |
| 2020 Q2 | 9.76 Million USD | -4.73% |
| 2020 Q3 | 10.37 Million USD | 6.21% |
| 2019 FY | 43.2 Million USD | 9.21% |
| 2019 Q1 | 10.23 Million USD | -1.7% |
| 2019 Q3 | 11.59 Million USD | 14.33% |
| 2019 Q4 | 11.24 Million USD | -3.04% |
| 2019 Q2 | 10.14 Million USD | -0.91% |
| 2018 Q3 | 10.43 Million USD | 9.84% |
| 2018 Q2 | 9.5 Million USD | 3.13% |
| 2018 FY | 39.56 Million USD | -1.05% |
| 2018 Q4 | 10.41 Million USD | -0.27% |
| 2018 Q1 | 9.21 Million USD | -15.44% |
| 2017 Q4 | 10.89 Million USD | 0.75% |
| 2017 FY | 39.98 Million USD | 15.91% |
| 2017 Q1 | 9.23 Million USD | 0.41% |
| 2017 Q2 | 9.03 Million USD | -2.07% |
| 2017 Q3 | 10.81 Million USD | 19.67% |
| 2016 Q3 | 8.55 Million USD | 0.58% |
| 2016 Q4 | 9.19 Million USD | 7.45% |
| 2016 Q1 | 8.24 Million USD | 14.82% |
| 2016 Q2 | 8.5 Million USD | 3.18% |
| 2016 FY | 34.49 Million USD | 12.56% |
| 2015 Q3 | 7.49 Million USD | -6.95% |
| 2015 Q4 | 7.17 Million USD | -4.19% |
| 2015 FY | 30.64 Million USD | -1.96% |
| 2015 Q2 | 8.05 Million USD | 1.7% |
| 2015 Q1 | 7.91 Million USD | 3.18% |
| 2014 FY | 31.25 Million USD | 35.78% |
| 2014 Q1 | 8.09 Million USD | 5.24% |
| 2014 Q2 | 7.89 Million USD | -2.4% |
| 2014 Q3 | 7.59 Million USD | -3.82% |
| 2014 Q4 | 7.67 Million USD | 1.05% |
| 2013 Q1 | 4.59 Million USD | -10.57% |
| 2013 Q4 | 7.68 Million USD | 27.72% |
| 2013 Q3 | 6.02 Million USD | 27.57% |
| 2013 Q2 | 4.71 Million USD | 2.74% |
| 2013 FY | 23.02 Million USD | 26.15% |
| 2012 Q3 | 4.31 Million USD | -4.01% |
| 2012 Q2 | 4.49 Million USD | 4.27% |
| 2012 Q1 | 4.3 Million USD | 21.6% |
| 2012 FY | 18.24 Million USD | 24.51% |
| 2012 Q4 | 5.13 Million USD | 19.1% |
| 2011 Q3 | 4.07 Million USD | 13.18% |
| 2011 Q4 | 3.54 Million USD | -12.95% |
| 2011 Q2 | 3.59 Million USD | 4.29% |
| 2011 FY | 14.65 Million USD | 11.08% |
| 2011 Q1 | 3.44 Million USD | -13.79% |
| 2010 Q2 | 2.8 Million USD | -1.34% |
| 2010 Q1 | 2.84 Million USD | -33.62% |
| 2010 FY | 13.19 Million USD | -25.02% |
| 2010 Q4 | 3.99 Million USD | 12.88% |
| 2010 Q3 | 3.54 Million USD | 26.22% |
| 2009 Q4 | 4.28 Million USD | -17.83% |
| 2009 Q2 | 5.64 Million USD | 130.31% |
| 2009 Q3 | 5.21 Million USD | -7.6% |
| 2009 Q1 | 2.45 Million USD | 30.35% |
| 2009 FY | 17.59 Million USD | 64.86% |
| 2008 Q4 | 1.88 Million USD | -23.87% |
| 2008 FY | 10.67 Million USD | 62.95% |
| 2008 Q2 | 3.81 Million USD | 52.09% |
| 2008 Q1 | 2.5 Million USD | 242.08% |
| 2008 Q3 | 2.47 Million USD | -35.27% |
| 2007 FY | 6.55 Million USD | 6.93% |
| 2007 Q4 | 733.45 Thousand USD | -64.87% |
| 2007 Q3 | 2.08 Million USD | 9.26% |
| 2007 Q2 | 1.91 Million USD | 5.12% |
| 2007 Q1 | 1.81 Million USD | 190.5% |
| 2006 FY | 6.12 Million USD | -83.95% |
| 2006 Q4 | 625.81 Thousand USD | -58.39% |
| 2006 Q3 | 1.5 Million USD | -53.01% |
| 2006 Q2 | 3.2 Million USD | 58.31% |
| 2006 Q1 | 2.02 Million USD | -76.66% |
| 2005 Q2 | 10.88 Million USD | 16.12% |
| 2005 FY | 38.17 Million USD | 40.35% |
| 2005 Q4 | 8.66 Million USD | -6.5% |
| 2005 Q1 | 9.37 Million USD | 15.83% |
| 2005 Q3 | 9.26 Million USD | -14.85% |
| 2004 Q4 | 8.08 Million USD | 14.94% |
| 2004 Q1 | 5.51 Million USD | -0.83% |
| 2004 Q2 | 6.55 Million USD | 18.77% |
| 2004 Q3 | 7.03 Million USD | 7.37% |
| 2004 FY | 27.2 Million USD | 33.25% |
| 2003 Q4 | 5.56 Million USD | 60.29% |
| 2003 FY | 20.41 Million USD | 10.74% |
| 2003 Q2 | 6.02 Million USD | 14.36% |
| 2003 Q3 | 3.47 Million USD | -42.4% |
| 2003 Q1 | 5.27 Million USD | -20.54% |
| 2002 Q2 | 3.27 Million USD | -20.53% |
| 2002 FY | 18.43 Million USD | 27.34% |
| 2002 Q4 | 6.63 Million USD | 50.66% |
| 2002 Q3 | 4.4 Million USD | 34.44% |
| 2002 Q1 | 4.12 Million USD | 4066.43% |
| 2001 FY | 14.47 Million USD | 19.69% |
| 2001 Q1 | 3.41 Million USD | -1.97% |
| 2001 Q4 | -103.89 Thousand USD | -101.48% |
| 2001 Q3 | 6.99 Million USD | 96.54% |
| 2001 Q2 | 3.56 Million USD | 4.31% |
| 2000 Q3 | 3.52 Million USD | 53.26% |
| 2000 Q4 | 3.48 Million USD | -1.23% |
| 2000 FY | 12.09 Million USD | 9.95% |
| 2000 Q1 | 2.6 Million USD | -18.75% |
| 2000 Q2 | 2.3 Million USD | -11.54% |
| 1999 Q2 | 2.7 Million USD | 12.5% |
| 1999 Q3 | 2.6 Million USD | -3.7% |
| 1999 Q4 | 3.2 Million USD | 23.08% |
| 1999 Q1 | 2.4 Million USD | 242.86% |
| 1999 FY | 11 Million USD | 74.6% |
| 1998 FY | 6.3 Million USD | 8.62% |
| 1998 Q4 | 700 Thousand USD | -65.0% |
| 1998 Q2 | 2 Million USD | 33.33% |
| 1998 Q3 | 2 Million USD | 0.0% |
| 1998 Q1 | 1.5 Million USD | -46.43% |
| 1997 Q3 | 800 Thousand USD | -33.33% |
| 1997 Q1 | 1 Million USD | 900.0% |
| 1997 FY | 5.8 Million USD | -9.38% |
| 1997 Q4 | 2.8 Million USD | 250.0% |
| 1997 Q2 | 1.2 Million USD | 20.0% |
| 1996 Q2 | 2.1 Million USD | -19.23% |
| 1996 Q4 | 100 Thousand USD | -92.86% |
| 1996 FY | 6.4 Million USD | -14.67% |
| 1996 Q1 | 2.6 Million USD | 471.43% |
| 1996 Q3 | 1.4 Million USD | -33.33% |
| 1995 Q2 | 2.9 Million USD | -6.45% |
| 1995 FY | 7.5 Million USD | -26.47% |
| 1995 Q1 | 3.1 Million USD | 0.0% |
| 1995 Q4 | -700 Thousand USD | -130.43% |
| 1995 Q3 | 2.3 Million USD | -20.69% |
| 1994 Q4 | 3.1 Million USD | 0.0% |
| 1994 FY | 10.2 Million USD | 6.25% |
| 1994 Q3 | 3.1 Million USD | 29.17% |
| 1994 Q2 | 2.4 Million USD | 20.0% |
| 1994 Q1 | 2 Million USD | 300.0% |
| 1993 FY | 9.6 Million USD | -18.64% |
| 1993 Q4 | 500 Thousand USD | -82.76% |
| 1993 Q2 | 3.3 Million USD | 17.86% |
| 1993 Q3 | 2.9 Million USD | -12.12% |
| 1993 Q1 | 2.8 Million USD | 100.0% |
| 1992 FY | 11.8 Million USD | -16.31% |
| 1992 Q1 | 3.9 Million USD | -26.42% |
| 1992 Q2 | 4.4 Million USD | 12.82% |
| 1992 Q3 | 3.2 Million USD | -27.27% |
| 1992 Q4 | 1.4 Million USD | -56.25% |
| 1991 Q2 | 5.4 Million USD | 5.88% |
| 1991 Q1 | 5.1 Million USD | -38.55% |
| 1991 Q4 | 5.3 Million USD | 12.77% |
| 1991 FY | 14.1 Million USD | -18.5% |
| 1991 Q3 | 4.7 Million USD | -12.96% |
| 1990 FY | 17.3 Million USD | 10.19% |
| 1990 Q1 | 8.3 Million USD | -27.83% |
| 1990 Q2 | 8.3 Million USD | 0.0% |
| 1990 Q3 | 8.3 Million USD | 0.0% |
| 1990 Q4 | 8.3 Million USD | 0.0% |
| 1989 Q2 | 11.5 Million USD | 0.0% |
| 1989 Q1 | 11.5 Million USD | 0.0% |
| 1989 FY | 15.7 Million USD | -33.19% |
| 1989 Q4 | 11.5 Million USD | 0.0% |
| 1989 Q3 | 11.5 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 2.55 Million USD | -1670.198% |
| BrainsWay Ltd. | 23.09 Million USD | -95.488% |
| Cerus Corporation | 86.4 Million USD | 47.755% |
| Envoy Medical, Inc. | -473 Thousand USD | 9643.35% |
| electroCore, Inc. | 13.22 Million USD | -241.298% |
| Helius Medical Technologies, Inc. | 61 Thousand USD | -73900.074% |
| IceCure Medical Ltd | 1.3 Million USD | -3372.311% |
| Inogen, Inc. | 126.69 Million USD | 64.372% |
| OrthoPediatrics Corp. | 111.25 Million USD | 59.426% |
| Lucid Diagnostics Inc. | -6.05 Million USD | 846.116% |
| Monogram Orthopaedics, Inc. | -47.33 Thousand USD | 95460.92% |
| MaxCyte, Inc. | 36.54 Million USD | -23.516% |
| NeuroOne Medical Technologies Corporation | 456.51 Thousand USD | -9787.922% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -52968.475% |
| Orthofix Medical Inc. | 486.27 Million USD | 90.717% |
| PAVmed Inc | -3.96 Million USD | 1237.602% |
| Rapid Micro Biosystems, Inc. | -5.48 Million USD | 922.973% |
| RxSight, Inc. | 53.76 Million USD | 16.042% |
| Sight Sciences, Inc. | 69.17 Million USD | 34.745% |
| SI-BONE, Inc. | 109.42 Million USD | 58.746% |
| TELA Bio, Inc. | 40.11 Million USD | -12.535% |
| Treace Medical Concepts, Inc. | 151.93 Million USD | 70.29% |
| Vivos Therapeutics, Inc. | 8.27 Million USD | -445.763% |
| Acutus Medical, Inc. | -3.13 Million USD | 1538.956% |
| Talis Biomedical Corporation | 371 Thousand USD | -12067.128% |
| Spectral AI, Inc. | 7.88 Million USD | -472.843% |
| Nano-X Imaging Ltd. | -6.59 Million USD | 784.77% |
| CVRx, Inc. | 33.03 Million USD | -36.627% |
| DIH Holding US, Inc. Warrants | - USD | -Infinity% |
| PetVivo Holdings, Inc. | 739.52 Thousand USD | -6003.916% |
| Bioventus Inc. | 328.19 Million USD | 86.246% |
| Venus Concept Inc. | 52.16 Million USD | 13.47% |
| TriSalus Life Sciences, Inc. | 15.9 Million USD | -183.793% |
| LivaNova PLC | 771.25 Million USD | 94.147% |
| 908 Devices Inc. | 25.32 Million USD | -78.264% |
| Alphatec Holdings, Inc. | 310.2 Million USD | 85.448% |
| Nemaura Medical Inc. | -1.47 Million USD | 3157.457% |
| NeuroPace, Inc. | 48.12 Million USD | 6.197% |
| LENSAR, Inc. | 21.1 Million USD | -113.863% |
| Apyx Medical Corporation | 14.12 Million USD | -219.643% |
| Cutera, Inc. | 41.49 Million USD | -8.787% |
| STRATA Skin Sciences, Inc. | 18.46 Million USD | -144.516% |
| BioSig Technologies, Inc. | 18 Thousand USD | -250678.028% |
| Anika Therapeutics, Inc. | 103.08 Million USD | 56.212% |
| ClearPoint Neuro, Inc. | 13.61 Million USD | -231.571% |
| Integra LifeSciences Holdings Corporation | 888.39 Million USD | 94.919% |
| Axonics, Inc. | 274.55 Million USD | 83.559% |
| Outset Medical, Inc. | 29 Million USD | -55.655% |
| IRIDEX Corporation | 21.8 Million USD | -106.998% |
| PROCEPT BioRobotics Corporation | 71.04 Million USD | 36.466% |
| IRadimed Corporation | 50.15 Million USD | 10.005% |
| Tivic Health Systems, Inc. | 287 Thousand USD | -15628.239% |
| INVO Bioscience, Inc. | 1.08 Million USD | -4056.014% |
| Telesis Bio, Inc. | 16.95 Million USD | -166.313% |
| Viemed Healthcare, Inc. | 112.78 Million USD | 59.976% |
| Varex Imaging Corporation | 256.9 Million USD | 82.429% |
| Quipt Home Medical Corp. | 163.84 Million USD | 72.45% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 11218.238% |
| Pulmonx Corporation | 50.75 Million USD | 11.058% |
| Dynatronics Corporation | 7.63 Million USD | -491.227% |
| Modular Medical, Inc. | -768 Thousand USD | 5977.61% |
| ReShape Lifesciences Inc. | 5.54 Million USD | -713.627% |
| Semler Scientific, Inc. | 61.2 Million USD | 26.242% |
| InMode Ltd. | 411.34 Million USD | 89.026% |
| Bruker Corporation | 1.51 Billion USD | 97.024% |
| Cytosorbents Corporation | 22.39 Million USD | -101.59% |
| DexCom, Inc. | 2.28 Billion USD | 98.028% |
| Align Technology, Inc. | 2.71 Billion USD | 98.34% |
| Viveve Medical, Inc. | 620 Thousand USD | -7180.652% |
| ZimVie Inc. | 290.38 Million USD | 84.455% |
| Movano Inc. | -158 Thousand USD | 28669.649% |
| Cytek Biosciences, Inc. | 109.42 Million USD | 58.748% |
| Nexalin Technology, Inc. | 85.06 Thousand USD | -52968.475% |
| DIH Holdings US, Inc. Class A Common Stock | - USD | -Infinity% |
| Tandem Diabetes Care, Inc. | 367.69 Million USD | 87.723% |
| Profound Medical Corp. | 4.51 Million USD | -899.996% |
| Insulet Corporation | 1.15 Billion USD | 96.108% |
| enVVeno Medical Corporation | -546 Thousand USD | 8367.408% |
| Surmodics, Inc. | 93.05 Million USD | 51.489% |
| iCAD, Inc. | 14.53 Million USD | -210.54% |
| Nuwellis, Inc. | 4.98 Million USD | -805.881% |
| Biotricity, Inc. | 8.35 Million USD | -440.193% |
| iRhythm Technologies, Inc. | 331.8 Million USD | 86.396% |
| Aethlon Medical, Inc. | -359.05 Thousand USD | 12671.833% |
| InspireMD, Inc. | 1.8 Million USD | -2398.066% |
| PAVmed Inc. | -3.96 Million USD | 1237.602% |
| BIOLASE, Inc. | 16.72 Million USD | -169.912% |
| Beyond Air, Inc. | -1.3 Million USD | 3553.714% |
| AxoGen, Inc. | 127.87 Million USD | 64.7% |
| Vivani Medical, Inc. | -357 Thousand USD | 12744.27% |
| Tactile Systems Technology, Inc. | 195.13 Million USD | 76.867% |
| Inari Medical, Inc. | 434.56 Million USD | 89.613% |
| UFP Technologies, Inc. | 112.22 Million USD | 59.777% |
| QT Imaging Holdings, Inc. | - USD | -Infinity% |
| Heart Test Laboratories, Inc. | 12.51 Thousand USD | -360472.29% |
| Tenon Medical, Inc. | 1.24 Million USD | -3537.393% |
| Autonomix Medical, Inc. Common Stock | -81 Thousand USD | 55828.451% |
| Co-Diagnostics, Inc. | 2.62 Million USD | -1618.253% |
| AdaptHealth Corp. | 479.56 Million USD | 90.587% |
| Sintx Technologies, Inc. | 1.84 Million USD | -2349.27% |
| NanoVibronix, Inc. | 1.53 Million USD | -2836.893% |
| Quanterix Corporation | 70.64 Million USD | 36.104% |
| Inspira Technologies Oxy B.H.N. Ltd. | -406 Thousand USD | 11218.238% |
| Sensus Healthcare, Inc. | 14.06 Million USD | -221.053% |
| Pacific Biosciences of California, Inc. | 52.78 Million USD | 14.475% |
| TransMedics Group, Inc. | 154.09 Million USD | 70.706% |
| ReWalk Robotics Ltd. | 4.45 Million USD | -913.7% |
| NeuroMetrix, Inc. | 3.94 Million USD | -1043.535% |
| Hyperfine, Inc. | 4.75 Million USD | -848.918% |
| Establishment Labs Holdings Inc. | 106.97 Million USD | 57.804% |
| Biomerica, Inc. | 611 Thousand USD | -7287.896% |
| Bone Biologics Corporation | - USD | -Infinity% |
| AVITA Medical, Inc. | 41.68 Million USD | -8.282% |
| Bluejay Diagnostics, Inc. | -780.95 Thousand USD | 5880.108% |
| Silk Road Medical, Inc | 127.08 Million USD | 64.481% |